Denali Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 2.8M | 2.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -2.8M | -2.9M | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 103.8M | 97.9M | 102.0M | 102.7M | 116.2M | 99.8M | 98.2M | 91.4M |
| Operating Expenses | 134.5M | 134.5M | 137.4M | 135.0M | 145.6M | 129.8M | 123.2M | 116.6M |
| Operating Income | -137.4M | -137.4M | -137.4M | -135.0M | -145.6M | -129.8M | -123.2M | -116.6M |
| Other Income / Gains | 8.9M | 8.9M | 10.5M | 10.8M | 12.6M | 15.2M | 16.0M | 17.6M |
| Net Income | -128.4M | -128.5M | -126.9M | -124.1M | -133.0M | -114.8M | -107.2M | -99.0M |
| EPS (Diluted) | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 0 | 35.5M | 32.3M | 29.4M | 30.1M | 24.9M | 25.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 30.7M | 36.6M | 35.5M | 32.3M | 29.4M | 30.1M | 24.9M | 25.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 137.4M | 137.4M | 137.4M | 135.0M | 145.6M | 129.8M | 123.2M | 116.6M |
| Interest Income | 8.9M | 8.9M | 10.5M | 10.8M | 12.6M | 15.2M | 16.0M | 17.6M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 2.8M | 3.8M | 3.9M | 4.0M | 3.2M | 2.6M | 2.3M | 1.9M |
| Ebitda | -134.5M | -124.7M | -133.6M | -131.0M | -142.4M | -127.2M | -120.9M | -114.7M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -128.4M | -128.4M | -126.9M | -124.1M | -133.0M | -114.7M | -107.2M | -99.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 102K | 0 | 0 | 0 | 68K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.69 | -0.73 | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 | -0.59 |
| Weighted Average Shs Out | 186.6M | 175.5M | 172.4M | 171.4M | 171.2M | 170.1M | 169.5M | 168.8M |
| Weighted Average Shs Out Dil | 186.6M | 175.5M | 172.4M | 171.4M | 171.2M | 170.1M | 169.5M | 168.8M |